Schecter Alison D. 4
4 · Axcella Health Inc. · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Schecter Alison D.
President - Research & Dev.
Transactions
- Award
Stock Option (Right to Buy)
2021-03-17+250,000→ 250,000 totalExercise: $5.57Exp: 2031-03-16→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on March 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.